# DESCRIPTION

## FIELD OF INVENTION

- introduce sigma-2 receptor binders

## BACKGROUND OF THE INVENTION

- identify sigma-1 and sigma-2 receptors
- describe sigma receptor sub-types
- discuss therapeutic utility of sigma-2 receptor binders
- highlight dysregulation of sigma-2 receptor activity
- mention cancer treatment opportunities

## BRIEF SUMMARY OF THE INVENTION

- introduce novel sigma-2 receptor binders
- define compounds of formula (I)
- describe R1a and R1b groups
- define R2 and R3 groups
- describe R4 and R5 groups
- outline compositions comprising compounds
- describe method for treating diseases
- outline process for preparing sigma-2 receptor binders

## DETAILED DESCRIPTION OF THE INVENTION

- motivate sigma-2 receptor modulators
- limitations of current treatments
- introduce need for new sigma-2 receptor binders
- describe diseases associated with sigma-2 receptor dysregulation
- summarize therapeutic potential of sigma-2 receptor modulators
- describe sigma-2 receptor binders and activity modulators
- outline treatment and prevention of diseases
- discuss overexpression of sigma-2 receptor
- define composition and process terms
- clarify language and terminology
- define halogen
- define alkyl and aliphatic groups
- define cycloalkyl, haloalkyl, alkoxy, and aryl groups
- define heterocyclic units
- define heteroaryl groups
- describe C1-C5 heteroaryl
- define fused ring units
- describe substituents
- define substituted moieties
- provide examples of substituents
- describe optional substituents
- define compounds, analogs, and compositions of matter
- describe stereoisomers and regioisomers
- describe pharmaceutically acceptable salts
- describe formation of salts
- define treating and treatment
- define terms
- describe subject patients
- introduce sigma-2 receptor binders
- define formula (I)
- describe compounds of formula (II)
- describe compounds of formula (IIa)
- describe compounds of formula (IIb)
- describe compounds of formula (IIc)
- define compounds
- specify formula (III)
- specify formula (IIIa)
- specify formula (IIIb)
- specify formula (IIIc)
- specify formula (IId)
- specify formula (IV)
- specify formula (IVa)
- specify formula (IVb)
- define compounds having formula Vc
- define compounds having formula Vd
- define compounds having formula VI
- define compounds having formula VIa
- define compounds having formula VIb
- define compounds having formula VIc
- define compounds having formula VId
- define compounds having formula VII
- define compounds having formula (VIIIb)
- define compounds having formula (VIIIc)
- define compounds having formula (VIIId)
- define compounds having formula (IX)
- define compounds having formula (IXa)
- define compounds having formula (IXb)
- define compounds having formula (IXc)
- define compounds having formula (IXd)
- specify embodiments of A
- specify embodiments of n
- specify embodiments of R1a and R1b
- specify embodiments of R2, R3, R4, R4a, R4b, and R4c
- define R4c embodiments
- define R4d embodiments
- define R4c embodiments
- define R5 embodiments
- define R5a embodiments
- define R5b embodiments
- define embodiments of R5b
- define embodiments of R5c and R5d
- define embodiments of R6, R7, R8a, R8b, and R9a
- define R9a embodiments
- define R9b embodiments
- define R9a and R9b ring embodiments
- define R10 embodiments
- define R11 embodiments
- define R12a and R12b embodiments
- list compound examples
- describe formula II embodiments
- describe formula X embodiments
- describe formula XI embodiments
- describe formula XII embodiments
- describe naming conventions

### Process

- outline preparation process
- describe standard synthetic methods
- discuss process monitoring and analysis
- explain protection and deprotection of chemical groups
- illustrate general synthetic schemes
- react compound 5 with compound 6
- react compound 9 with compound 10
- react compound 13 with compound 14
- react compound 17 with compound 18
- treat compound 19 with paraformaldehyde
- convert compound 21 to compound 22
- react compound 22 with compound 23
- react compound 25 with compound 26
- treat compound 27 with paraformaldehyde
- convert compound 29 to compound 30
- react compound 30 with compound 31
- react compound 33 with base
- react compound 34 with iodine
- react compound 35 with compound 36
- react compound 38 with ruthenium chloride
- react compound 44 with compound 45

### EXAMPLES

- introduce examples of the invention
- provide representative methods for preparing compounds
- describe preparation of methyl 2,2-dimethylpent-4-enoate
- describe preparation of ethyl 2,2-diethylpent-4-enoate
- describe preparation of 1-allylcyclobutanecarboxylic acid
- describe preparation of 1-allylcyclopentanecarboxylic acid
- describe preparation of 1-allylcyclohexanecarboxylic acid
- describe preparation of 5-(2-Hydroxy-ethyl)-3,3-dimethyl-dihydro-furan-2-one
- describe preparation of 3,3-diethyl-5-(2-hydroxyethyl)dihydrofuran-2(3H)-one
- describe preparation of 7-(2-hydroxyethyl)-6-oxaspiro[3.4]octan-5-one
- describe preparation of 3-(2-hydroxyethyl)-2-oxaspiro[4.4]nonan-1-one
- describe preparation of 2-(4,4-dimethyl-5-oxotetrahydrofuran-2-yl)ethyl 4
- prepare compounds
- prepare 2-(5-oxo-6-oxaspiro[3.4]octan-7-yl)ethyl 4
- prepare 2-(1-oxo-2-oxaspiro[4.4]nonan-3-yl)ethyl 4
- prepare 2-(1-oxo-2-oxaspiro[4.5]decan-3-yl)ethyl 4
- prepare 5-(2-bromoethyl)-3,3-diethyldihydrofuran-2(3H)-one
- prepare 3-(2-bromoethyl)-2-oxaspiro[4.5]decan-1-one
- prepare 2,2-diethylpent-4-enoic acid
- prepare 3,3-diethyl-5-(iodomethyl)dihydrofuran-2(3H)-one
- prepare 3-(iodomethyl)-2-oxaspiro[4.4]nonan-1-one
- prepare 3-(iodomethyl)-2-oxaspiro[4.5]decan-1-one
- prepare 3-hydroxy-2-oxaspiro[4.4]nonan-1-one
- prepare 3-hydroxy-2-oxaspiro[4.5]decan-1-one
- provide example 27
- provide example 28
- provide example 29
- provide example 30-33
- provide example 34-36
- provide additional examples
- describe example 37
- describe example 38
- describe example 39
- describe examples 40-42
- describe examples 43-44
- describe examples 45-46
- provide examples
- prepare tert-butyl 5-(m-tolyl)hexahydropyrrolo[3,4-c]pyrrole-2(
- prepare tert-butyl 5-(p-tolyl)hexahydropyrrolo[3,4-c]pyrrole-2(
- prepare tert-butyl 5-(2-methoxyphenyl)hexahydropyrrolo[3,4-c]pyrrole-
- prepare tert-butyl 5-(3-methoxyphenyl)hexahydropyrrolo[3,4-c]pyrrole-
- prepare tert-butyl 5-(4-methoxyphenyl)hexahydropyrrolo[3,4-c]pyrrole-
- describe example 57
- describe example 58
- describe example 59
- describe examples 60-64
- describe examples 65-66
- provide examples
- prepare compounds
- prepare compounds
- prepare compounds
- prepare compounds
- prepare compounds
- prepare compounds
- prepare compounds
- prepare compounds
- prepare compounds
- describe synthesis of compounds
- provide NMR data for compounds
- describe purification methods for compounds
- provide MS data for compounds
- describe reaction conditions for compounds
- provide structural information for compounds
- describe substitution reactions for compounds
- provide yield information for compounds
- describe example 96
- describe example 97
- describe example 98
- describe example 99
- describe example 100
- describe example 101
- describe example 102
- describe examples 103-105
- describe examples of compounds
- describe examples of compounds
- describe examples of compounds
- describe examples of compounds
- introduce formulations
- define excipient
- describe role of excipient
- describe pharmaceutical compositions
- describe oral formulations
- describe solid carriers
- describe liquid carriers
- describe parenteral administration
- describe unit dosage forms
- describe effective dosage
- describe administration methods
- describe transdermal administration
- describe transdermal administration
- describe rectal and vaginal administration
- describe lipid formulations and nanocapsules
- describe combination therapy
- describe pharmaceutical compositions
- outline procedure for evaluating sigma-2 receptor binders

